Skip to main content

Table 6 Laboratory findings among the studied cases and comparison according to liver fibrosis

From: Clinical and diagnostic characteristics of non-alcoholic fatty liver disease among Egyptian children and adolescents with type1 diabetes

Variables

Fibrosis

P-value

Present (N = 46)

Absent (N = 28)

Hemoglobin

13.0 ± 1.3

13.4 ± 1.4

^0.193

RBC

4.7 ± 0.5

4.9 ± 0.5

^0.219

Hematocrit

38.2 ± 4.1

39.7 ± 4.0

^0.118

MCHC

34.0 ± 0.8

33.7 ± 1.0

^0.219

TLC

12.4 ± 5.6

12.2 ± 5.6

^0.840

Platelets

359.8 ± 83.8

346.1 ± 87.5

^0.504

Cholesterol

157.5 ± 45.8

134.1 ± 35.0

^0.022*

Triglycerides

130.8 ± 90.8

95.9 ± 29.3

^0.020*

HDL

53.5 ± 9.5

51.3 ± 7.0

^0.296

LDL

75.2 ± 34.9

64.8 ± 23.9

^0.164

FBG

214.0 ± 79.3

219.6 ± 70.7

^0.762

HbA1c

10.2 ± 1.7

10.3 ± 2.4

^0.881

No. of cases with HbA1c ≥ 10.0

24 (52.2%)

16 (57.1%)

#0.877

Mean HbA1c/y

10.7 ± 1.8

10.8 ± 2.2

^0.702

No. of cases with mean HbA1c ≥ 10.0/y

30 (65.2%)

20 (71.4%)

#0.837

AST

28.7 ± 23.1

20.6 ± 6.1

^0.069

No. of cases with abnormal AST

9 (19.6%)

0 (0.0%)

§0.010*

ALT

16.1 ± 10.3

11.7 ± 3.2

^0.028*

No. of cases with abnormal ALT

3 (6.5%)

0 (0.0%)

§0.275

  1. ^Independent t-test
  2. #Chi square test
  3. §Fishers exact test
  4. *Significant (p < 0.05)